Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thin Glomerular Basement Membrane Phenotypes With No Identified Pathogenic <i>COL4A3/A4/A5</i> Variant.

Kidney international reports·2026
Same author

Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

A phase I/II study of twice-weekly ixazomib plus pomalidomide and dexamethasone in relapsed and refractory multiple myeloma.

Haematologica·2026
Same author

Pathogenesis and kidney prognosis of renal amyloidosis.

Cellular and molecular life sciences : CMLS·2026
Same author

Assessment of cardiac involvement in rare forms of amyloidosis using positron emission tomography/computed tomography with <sup>124</sup>I-evuzamitide (<sup>124</sup>I-p5+14, AT-01).

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2026
Same author

Cardiovascular Adverse Events Associated With Bispecific T-Cell Engager Therapy.

JACC. CardioOncology·2026
Same journal

Cell Trafficking in Chronic Lymphocytic Leukemia.

Open journal of hematology·2012
Same journal

Novel agents in Waldenstrom Macroglobulinemia.

Open journal of hematology·2012
See all related articles

Related Experiment Video

Updated: May 10, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Cell Trafficking in Multiple Myeloma.

Giada Bianchi1, Shaji Kumar, Irene M Ghobrial

  • 1Mayo Clinic, Rochester, MN, USA.

Open Journal of Hematology
|June 14, 2013
PubMed
Summary
This summary is machine-generated.

Multiple myeloma (MM) is a bone marrow cancer where cancer cells interact with bone marrow stroma cells, leading to drug resistance. Understanding MM cell homing and interactions is key to developing new therapies.

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Related Experiment Videos

Last Updated: May 10, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Area of Science:

  • Hematology
  • Oncology
  • Cancer Biology

Background:

  • Multiple myeloma (MM) is a prevalent, incurable hematologic malignancy.
  • MM cells thrive in the bone marrow niche, interacting with bone marrow stroma cells (BMSC) and extracellular matrix (ECM).
  • This niche promotes MM cell survival and confers resistance to chemotherapy.

Purpose of the Study:

  • To investigate the mechanisms regulating MM cell homing to the bone marrow.
  • To understand the interactions between MM cells and BMSCs.
  • To identify pathways involved in MM cell trafficking to distant bone sites.

Main Methods:

  • The abstract does not specify methods.
  • Further research is needed to elucidate the specific methodologies employed.

Main Results:

  • The abstract does not specify results.
  • Further research is needed to elucidate the specific findings.

Conclusions:

  • Identifying mechanisms of MM cell homing and BMSC interaction is crucial.
  • Understanding these processes may lead to novel therapies for MM.
  • Targeting the bone marrow niche interactions could be a strategy to overcome drug resistance and find a cure for MM.